國內基因定序領導大廠基龍米克斯生物科技股份有限公司（以下簡稱“基米”，股票代碼：4195）今（18）日抛磚引玉捐贈20萬元，支持郭泓志運動發展協會推行的首個公益活動「完膳自我-愛心待用餐」，希望讓偏鄉或弱勢孩童在接受棒球訓練的同時能獲得足夠營養，心無旁騖的專心練球。
基龍米克斯董事長周孟賢表示，自己從小就喜愛棒球，對郭泓志在旅美時期便長期投以關注，去年5月「郭泓志運動發展協會」正式成立後，看到他親自指導偏鄉球隊的孩子打球與爭取相關資源，深受感動，決定與協會合作，加入響應行列，貢獻一己之力。
本次捐贈是響應該協會發起的「完膳自我-愛心待用餐」公益活動，這也是國內首度透過智慧販賣機做待用餐的模式，只要掃QR Code即可取餐，快速方便且無接觸，重點是還能兼顧食安與收受者的尊嚴，不受異樣眼光。周孟賢表示會持續支持該協會，希望善行能繼續推動下去，涵蓋包括棒球運動在內更多社會層面的愛與關懷。
周孟賢指出，成立公司就是一種社會責任，每1位員工背後都是1個家庭，基龍米克斯現在有200多位員工，讓這200個家庭都好，也是公司的社會責任。基龍米克斯的一個目標是希望和員工共同攜手回饋社會，目前公司每年至少針對20-30個弱勢族群、育幼院或偏遠地區慈善單位進行捐助，並鼓勵員工自發性參與、身體力行，廣植福田，讓整體慈善循環擴散到全台灣。
Other News
Joseph Chou, President of Genomics BioSci & Tech. Co. Ltd., Taiwan’s leading genetic sequencing company (hereafter referred to as “Genomics”, stock code: 4195), announced today (24th) the company’s first nucleic acid adjuvant product will apply for PIC/S GMP inspection with the TFDA in the third quarter of this year. Genomics is expected to become the first manufacturer in Taiwan to focus on the development and scaled production of high quality nucleic acid adjuvants. This is not only a significant milestone in the company’s transformational process, but also contributes to the effectively patching of the gaps in local supply chains, replacing the reliance on importation and conferring significant benefits to the overall development of the domestic biotechnology industry.
Benefiting from the increased demands of testing services and equipment procurement from the scientific research organizations and the contributions from the sales of the newly added agency of COVID-19 rapid screening products, the consolidated revenue of Genomics for the previous year was NT$419 million, an annual growth of 7.45%. In terms of profits, due to the investment in the construction of GMP plant and expenditures on expansion of R&D teams, the core business has experienced losses, but with upgraded laboratory equipment and process optimization, the gross margin has increased from 28% in 2021 to 32% in 2022. In addition, the profit from the disposal of reinvested stocks pushed up the net profit attributable to the parent company's owners to NT$71.59 million, which is a significant increase of 282% from the previous year, and the after-tax earnings per share (EPS) was NT$1.15.
Top
Contact
Contact Us
Contact
Contact Us
Back
Service
overview
